Skip to content
Screener

Hims & Hers Health HIMS Cash & Equivalents

Cash & Equivalents at other companies

WW International, Inc. logo
WW International, Inc.WW
$101.5M-27.8%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$34.48M+7.9%
Amazon logo
AmazonAMZN
$78.21B+35.5%
Teladoc Health logo
Teladoc HealthTDOC
$774.35M+13.9%
Veradermics logo
VeradermicsMANE
$168.41M+419%
PBH
Prestige Consumer HealthcarePBH
$89.13M-36.1%

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$7.33B-36.6%
Enterprise value$7.26B-30.9%
P/S3.1×-2.6×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Hims & Hers Health’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001773751-26-000076
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Foreign currency effect on cash and cash equivalents(2,380)243
(Decrease) increase in cash, cash equivalents, and restricted cash(6,350)53,519
Cash, cash equivalents, and restricted cash at beginning of period228,616221,440
Cash, cash equivalents, and restricted cash at end of period$222,266$274,959
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents$222,266$273,736
Restricted cash1,223
Total cash, cash equivalents, and restricted cash$222,266$274,959

Item 1. Financial Statements

FAQ

What is Hims & Hers Health's cash & equivalents?
Hims & Hers Health (HIMS) reported cash & equivalents of $222.27M in Q1 2026.
How has Hims & Hers Health's cash & equivalents changed year-over-year?
Hims & Hers Health's cash & equivalents decreased by 19.2% year-over-year, from $274.96M to $222.27M.
What is the long-term trend for Hims & Hers Health's cash & equivalents?
Over 5 years (2020 to 2025), Hims & Hers Health's cash & equivalents has grown at a 190.8% compound annual growth rate (CAGR), from $1.1M to $228.62M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Hims & Hers Health's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude